Gene C. Mack

Gene C. Mack

Director of Finance/CFO at GAIN THERAPEUTICS, INC.

50 year
Finance
Health Technology
Government

Profile

Mr. Gene C.
Mack
is a Chief Financial Officer & Secretary at Gain Therapeutics, Inc. Mr. Mack was previously employed as a Chief Financial Officer by ImCyse SA, a Chief Financial Officer & Treasurer by SELLAS Life Sciences Group, Inc., a Chief Financial Officer & Senior Vice President by Ascendia Pharmaceuticals, Inc., a Senior Director-Finance & Investor Relations by Edge Therapeutics, Inc., a Managing Director by Brean Capital LLC, an Executive Director by MIZUHO SECURITIES USA INC, a Research Analyst by Soleil Securities Corp., a Research Analyst by Lazard Capital Markets LLC, an Analyst by HSBC Securities (USA), Inc., an Analyst by Gruntal & Co. LLC, a Chief Financial Officer by OncoC4, Inc., and an Analyst by Ryan, Beck & Co., Inc. He received his undergraduate degree from Fordham University and an MBA from Fordham University.

Gene C. Mack active positions

CompaniesPositionStart
GAIN THERAPEUTICS, INC. Director of Finance/CFO 2024-04-07
All active positions of Gene C. Mack

Former positions of Gene C. Mack

CompaniesPositionEnd
Director of Finance/CFO 2023-09-30
SELLAS LIFE SCIENCES GROUP, INC. Director of Finance/CFO 2018-12-16
Director of Finance/CFO 2016-12-31
Investor Relations Contact 2014-12-31
Analyst-Equity 2014-02-28
See the detail of Gene C. Mack's experience

Training of Gene C. Mack

Fordham University Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Gene C. Mack's experience

Connections

100 +

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
SELLAS LIFE SCIENCES GROUP, INC.

Health Technology

GAIN THERAPEUTICS, INC.

Health Technology

Private companies11

Finance

Finance

Finance

Finance

Health Technology

Finance

Gruntal & Co. LLC

Government

Finance

Health Technology

Health Technology

Oncoc4, Inc.

See company connections